How COVID-19 will Affect the Psychedelic Renaissance
Following the SARS virus outbreak in 2003, various studies detailed increased cases of depression and post-traumatic stress disorder. As the outbreak of the current...
Cannabis And Ketamine: Is There A Risk Of Interaction?
With more research on the horizon, those suffering with severe depression may find reprieve in ketamine and cannabis.
Used for thousands of years, cannabis ignites...
Researchers Think a K-Hole Might Actually Be the Brain Going Offline
A team of scientists at Cambridge may have accidentally discovered why k-holes feel so much like near-death experiences.
A team of scientists from the University...
Why The Future Of Mental Health Care May Lie In Psychedelics
Despite the fact that most non-COVID medical research and funding has come to a halt during the pandemic, there is one emerging field that...
The American Society of Ketamine Physicians (ASKP) Announces Name Change
The American Society of Ketamine Physicians (ASKP) was formed in 2016 after the original founders met at the KRIYA conference and chose to form...
Beaumont launches study on whether two common drugs can treat COVID-19
Beaumont Hospital researchers are hoping that two common drugs can help treat COVID-19 patients.
The drugs are naltrexone and ketamine. Naltrexone is used to treat inflammatory pain conditions and...
Ketamine Therapy Essential Service During COVID-19 Pandemic
It goes without saying that COVID-19 is on the minds of nearly every American. The societal and economic disruption is almost without precedent. As...
‘Impressed With Impact’ of Ketamine in Cancer Palliative Care
Like many in her field, Toronto psychiatrist Madeline Li, MD, PhD, was skeptical when one of her psychiatry residents suggested they launch a study...
SLS-002 Intranasal Ketamine Depression Drug Granted Fast Track Status by FDA
Seelos Therapeutics Inc (NASDAQ:SEEL) stock soared Monday after its SLS-002 intranasal ketamine depression drug aimed at patients with post-traumatic stress disorder (PTSD) and major depressive...
The U.S. Government Must Ensure Open Access to Ketamine Infusions
Ketamine, which is a drug most commonly used to induce and maintain anesthesia, was developed in the late 1950s and approved for use in...
- Advertisement -
Latest article
Helping a Friend with Depression
Helping a Friend with Depression
Let’s say you have a friend who was once the life of the party, but now they’re more quiet or...
New Spravato FDA Approval Opens The Door to New Patients, Says Sandhya Prashad, M.D.
A new indication of Janssen’s ketamine based-nasal spray Spravato (intranasal esketamine) has been approved for rapid reduction of depression symptoms in those with major...
Shamanism in the Modern Age
“Webster’s Dictionary defines Shamanism as…”
That would be the cliche way to start something like this. And in all honesty, it’s probably exactly how I...
